Recent Comments
- LB on Plastic Surgeons Comment on Transgender Surgery
- Linda ODonnell on Senator Ron Johnson explains why he got an antibody test before considering a vaccine (i.e., The Greer Protocol)
- Gary on The “surge in new Wuhan virus cases” is great news
- Catherine on The “surge in new Wuhan virus cases” is great news
- admin on Far-left NeverTrump propaganda has hijacked the peer-review process
Most Viewed Posts
- New treatment paradigm for C. Diff colitis (13,200)
- Gordon Guyatt, MD: Update on the problem of clinical trials being stopped early to inflate efficacy of drugs (13,197)
- How the FDA regulates compounding pharmacies (12,930)
- I discuss the handling of the COVID-19 outbreak on The Joe Piscopo radio show (12,548)
- The Healthcare Channel hits 10 (11,183)
- The new CDC guidelines for prescribing opioid pain pills (7,395)
- Exclusive: Michael Bloomberg took control of Johns Hopkins with his billions. Then, death rates skyrocketed at a children’s hospital. (6,471)
- The Who’s Teen Cancer Lounge at Sloan Kettering opens (6,179)
- The MusiCorps benefit concert 2015 (5,454)
- The Medical Advocate (4,927)
Pages
Categories
- – Biotech
- – Generics
- – JAMA
- – Medical Devices
- – NEJM
- – Opinion
- – Pharma
- – Policy
- – Reviews, books, devices
- – The Weekly Summary
- Bariatric surgery
- Cardiac surgery
- Cardiology
- Dermatology
- Diabetes and endocrinology
- Emergency medicine
- Gastroenterology and liver
- General surgery
- Genetics
- Geriatrics
- Infectious disease
- Internal Medicine
- Neurology
- Neurosurgery
- Obstetrics and Gynecology
- Oncology
- Ophthalmology
- Orthopedic surgery
- Pediatrics
- Plastic surgery
- Primary care medicine
- Psychology Psychiatry
- Pulmonology
- Radiology
- Rheumatology
- Spine surgery
- Sports medicine
- Transplant surgery
- Trauma Surgery
- Uncategorized
- Urology
- Vascular Surgery
- Z Medical centers
- Baylor
- Boston University
- Cedars Sinai
- Cleveland Clinic
- Columbia
- Cornell
- Duke
- Emory
- George Washington Univ
- Harvard
- Henry Ford
- Iowa State
- Johns Hopkins
- Mayo Clinic
- McMaster University
- Medical University of South Carolina
- Memorial Sloan-Kettering
- Michigan
- National Jewish Health
- NYU
- Ohio State
- Oregon Health and Science University
- UC Davis
- UC San Francisco
- UCLA
- Univ Kentucky
- Univ Maryland
- Univ Miami
- Univ Michigan
- Univ of Louisville
- Univ Texas
- VA Walter Reed
- Vanderbilt
- VCU
- Washington University
- Yale
Category Archives: Gastroenterology and liver
Daily aspirin once again proves to be of no use and also deadly
Update January 13, 2015- Yet another study was published highlighting the risks of daily aspirin.
Celiac disease is not reduced by breast feeding or delaying the introduction of gluten
October 19, 2014- Interviewed by Steven E. Greer, MD Alessio Fasano, MD of Harvard discusses his 10-year-long study in children testing whether the
Eluxadoline (Viberzi) to treat Irritable Bowel Syndrome
January 20, 2016- Produced, Interviewed by Steven E. Greer, MD We interviewed Anthony Lembo, MD of The Beth Israel Deaconess Hospital to discuss his
Posted in - NEJM, - Pharma, Gastroenterology and liver, Harvard
Leave a comment
Once again, daily aspirin is shown to be deadly rather than beneficial
September 16, 2018- by Steven E. Greer, MD The Healthcare Channel has been pounding the table for many years pushing back against the drug
The Gluten Crazies are out of control and affecting menus in restaurants
April 26, 2015- By Steven E. Greer, MD I was eating at a French restaurant recently, and the waiter asked me if I had any allergies, such as “gluten”.
Posted in - Opinion, Gastroenterology and liver, Harvard, Pediatrics
Leave a comment
New treatment paradigm for C. Diff colitis
March 31, 2010- Produced and interviewed by Steven E. Greer, MD New drugs
Interview with the CEO of Synthetic Biologics, Jeff Riley
February 8, 2016- Interviewed by Steven E. Greer, MD
Cutting through the hype surrounding gluten
October 19, 2014- Interviewed by Steven E. Greer, MD Did you know that one out of three Americans think that they are “gluten intolerant”. Of those 100
Posted in - NEJM, - Policy, Gastroenterology and liver, Pediatrics
Leave a comment
New therapies for hepatitis C
November 6, 2013- Interviewed by Steven E. Greer, MD In Part 1, Sammy Saab, MD, MPH, liver disease and GI doctor from UCLA, discusses the standard of care